These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16243592)

  • 1. The general practitioner's approach to irritable bowel syndrome: from intention to practice.
    Bellini M; Tosetti C; Costa F; Biagi S; Stasi C; Del Punta A; Monicelli P; Mumolo MG; Ricchiuti A; Bruzzi P; Marchi S
    Dig Liver Dis; 2005 Dec; 37(12):934-9. PubMed ID: 16243592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How general practitioners manage patients with irritable bowel syndrome. Data from a German urban area.
    Franke A; Singer MV; Dumitraşcu DL
    Rom J Intern Med; 2009; 47(1):47-53. PubMed ID: 19886069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of irritable bowel syndrome using a Rome II-based classification.
    Williams RE; Black CL; Kim HY; Andrews EB; Mangel AW; Buda JJ; Cook SF
    Aliment Pharmacol Ther; 2006 Jan; 23(1):197-205. PubMed ID: 16393298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.
    Whitehead WE; Palsson OS; Feld AD; Levy RL; VON Korff M; Turner MJ; Drossman DA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):137-46. PubMed ID: 16803612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers.
    Faresjö A; Grodzinsky E; Foldevi M; Johansson S; Wallander MA
    Aliment Pharmacol Ther; 2006 Mar; 23(6):807-14. PubMed ID: 16556183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of irritable bowel syndrome among undergraduates in Southeast China.
    Dai N; Cong Y; Yuan H
    Dig Liver Dis; 2008 Jun; 40(6):418-24. PubMed ID: 18339591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usual medical care for irritable bowel syndrome.
    Whitehead WE; Levy RL; Von Korff M; Feld AD; Palsson OS; Turner M; Drossman DA
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1305-15. PubMed ID: 15606392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006].
    Seifert B; Lukás K; Charvátová E; Vojtísková J; Koudelka T; Hep A; Bures J; Jirásek V; Díte P
    Cas Lek Cesk; 2007; 146(1):17-23. PubMed ID: 17310580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L; Elia C; Navino M; Cisarò F;
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
    Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
    Hungin AP; Chang L; Locke GR; Dennis EH; Barghout V
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1365-75. PubMed ID: 15932367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomised controlled trial.
    Daley AJ; Grimmett C; Roberts L; Wilson S; Fatek M; Roalfe A; Singh S
    Int J Sports Med; 2008 Sep; 29(9):778-82. PubMed ID: 18461499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, diagnostic and symptom profile of patients receiving tegaserod in routine clinical practice in Canada.
    Bradette M; Wawer AR; Balshaw R; Kelly S; Barbeau M; Sambrook R
    Can J Clin Pharmacol; 2007; 14(3):e291-300. PubMed ID: 18025544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of a general therapeutic approach in subjects with irritable bowel syndrome.
    Monsbakken KW; Vandvik PO; Farup PG
    Aliment Pharmacol Ther; 2005 Jan; 21(1):21-7. PubMed ID: 15644041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.